Search results
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 19 hours ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Shah Capital seeks board overhaul at Novavax By Investing.com
Investing.com· 13 hours agoShah Capital Management, a major shareholder in Novavax Inc. (NASDAQ:NVAX), has publicly expressed...
Novavax’s top shareholder Shah Capital ramps up efforts for board shakeup
WHTC 1450 Holland· 17 hours ago(Reuters) - Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Federated Hermes Inc.
ETF DAILY NEWS· 1 day agoFederated Hermes Inc. lowered its position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 88.6% in the fourth quarter, according to the company in its most recent ...
Novavax investor Shah Capital to vote against three directors
Reuters via Yahoo Finance· 21 hours agoMay 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker Novavax. Shah Capital ...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 6 days agoIn the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 15 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Q1 2024 Enovix Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoBefore we continue, let me kindly remind you that we released our first quarter 2024 shareholder letter after the market close today is available on our website at ir dot novavax< ...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 5 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...